Modulation of Muscarinic Signalling in the Central Nervous System by Steroid Hormones and Neurosteroids

Int J Mol Sci. 2022 Dec 28;24(1):507. doi: 10.3390/ijms24010507.

Abstract

Muscarinic acetylcholine receptors expressed in the central nervous system mediate various functions, including cognition, memory, or reward. Therefore, muscarinic receptors represent potential pharmacological targets for various diseases and conditions, such as Alzheimer's disease, schizophrenia, addiction, epilepsy, or depression. Muscarinic receptors are allosterically modulated by neurosteroids and steroid hormones at physiologically relevant concentrations. In this review, we focus on the modulation of muscarinic receptors by neurosteroids and steroid hormones in the context of diseases and disorders of the central nervous system. Further, we propose the potential use of neuroactive steroids in the development of pharmacotherapeutics for these diseases and conditions.

Keywords: Alzheimer’s disease; Parkinson’s disease; cholesterol; depression; muscarinic receptors; neuroactive steroids; neurosteroids; schizophrenia; substance abuse.

Publication types

  • Review

MeSH terms

  • Central Nervous System
  • Cholinergic Agents
  • Hormones
  • Neurosteroids* / pharmacology
  • Receptors, Muscarinic
  • Steroids / pharmacology
  • Steroids / physiology

Substances

  • Neurosteroids
  • Steroids
  • Hormones
  • Receptors, Muscarinic
  • Cholinergic Agents